Table 2.
The characteristics of survivors and non-survivors during extracorporeal membrane oxygenation support
| Non-survivors | Survivors | p-value | |
|---|---|---|---|
| n = 34 | n = 31 | ||
| ECMO modes | 0.018 | ||
| VA mode | 31 | 21 | |
| Change from VA to VV | - | 1 | |
| Change from VA to V-AV | 1 | - | |
| Change from VA to V-AV, and then to VV | - | 1 | |
| V-AV mode | 2 | 1 | |
| Change from V-AV to VV | 1 | - | |
| VV mode | 1 | 9 | |
| Anticoagulants | 0.179 | ||
| Nafamostat mesilate | 30 | 26 | |
| Heparin | 2 | 5 | |
| ECMO run of ≤24 h | 9 | 1 | 0.014a |
| Surgery after ECMO | - | 4 | 0.046a |
| ECMO duration, h | 72.5 (23.8, 118) | 143.0 (93, 212) | 0.001 |
| CRRT | 18 (60 %) | 5 (71 %) | 0.687a |
| Daily blood transfusion, unit/d | - | - | |
| Packed red blood cells | 1.9 (0.9, 3.0) | 1.0 (0.7, 1.3) | 0.002 |
| Fresh frozen plasma | 1.0 (0.5, 2.4) | 0.3 (0.0, 0.7) | 0.001 |
| Platelet concentrate | 1.7 (0.0, 5.0) | 1.3 (0.0, 3.3) | 0.823 |
| Length of stay | |||
| ICU | 4 (2, 7) | 18 (11, 30) | <0.001 |
| Hospital | 4 (2, 7) | 28 (20, 51) | <0.001 |
aFisher’s exact test. Continuous variables are reported as median (interquartile range)
ECMO extracorporeal membrane oxygenation, VA veno-arterial, VV veno-venous, V-AV veno-arteriovenous, CRRT continuous renal replacement therapy, ICU intensive care unit
Surgeries included two pulmonary artery thromboembolectomies, a left upper lobectomy, and an aneurysm clipping via a left frontotemporal craniectomy